Brief: LifeMD Q2 adjusted EPS USD 0.05
09/08/2023 22:48
Aug 9 (Reuters) - LifeMD Q2 adjusted EPS USD 0.05. * Q2 gross margin 87% * Q2 adjusted EBITDA USD 1.7 million * Q2 revenue USD 35.9 million vs. IBES estimate USD 35.2 million * Q2 net income USD -7.5 million * Outlook FY adjusted EBITDA USD 10-13 million
Recent news on LifeMD
See all newsLifeMD Q1 revenue beats estimates on record telehealth subscriber additons
Brief: LifeMD Q1 Adjusted EBITDA USD -4.5 Million Vs. IBES Estimate USD -4.66 Million
LifeMD rises after adding new daily obesity pill to weight management program
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US (updated)
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US